Persistent/Recurrent Differentiated Thyroid Cancer: Clinical and Radiological Characteristics of Persistent Disease and Clinical Recurrence Based on Computed Tomography Analysis

被引:7
|
作者
Kim, Taek Min [1 ,2 ]
Kim, Ji-hoon [1 ,2 ,5 ]
Yoo, Roh-Eul [1 ,2 ]
Kim, Soo Chin [6 ]
Chung, Eun-Jae [3 ]
Hong, Eun Kyoung [1 ,2 ]
Jo, Sangwon [1 ,8 ]
Kang, Koung Mi [1 ,2 ]
Choi, Seung Hong [1 ,2 ,5 ]
Sohn, Chul-Ho [1 ,2 ,5 ]
Rhim, Jung Hyo [7 ]
Park, Sun-Won [2 ,7 ]
Park, Young Joo [4 ]
机构
[1] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Radiol, 101 Daehak Ro, Seoul 110744, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[5] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea
[6] Seoul Natl Univ Hosp Healthcare Syst, Dept Radiol, Gangnam Ctr, Seoul, South Korea
[7] SMG SNU Boramae Med Ctr, Dept Radiol, Seoul, South Korea
[8] Kangbuk Samsung Hosp, Dept Radiol, Seoul, South Korea
关键词
thyroid cancer; ultrasonography; computed tomography; recurrence; persistent; PAPILLARY MICROCARCINOMA; RISK STRATIFICATION; LYMPH-NODES; MANAGEMENT; CARCINOMA; NODULES; SURVEILLANCE; EFFICACY; RECOMMENDATIONS; PROGRESSION;
D O I
10.1089/thy.2018.0151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The natural course of persistent/recurrent differentiated thyroid cancer (DTC) has not been fully elucidated. The purpose of this study was to assess the relative incidence and clinico-radiological characteristics of persistent disease and clinical recurrence based on computed tomography (CT) analysis in patients with persistent/recurrent DTC. Methods: From January 2005 to December 2016, this retrospective study included 107 patients (M:F = 28:79; M-age = 53.5 years) with surgically proven cervical locoregional recurrence of DTC. Two neck CT examinations (median interval 1.92 years; range 0.17-7.58 years) before the last thyroid cancer surgery within the study period were reevaluated. Based on the presence of the lesion on the first CT and its progression on the second CT, the locoregional recurrence was classified into the following categories: stable persistence (decrease, no change, or increase by <2 mm in short dimension on the second CT), progressive persistence (increase by >= 2 mm), and clinical recurrence (newly appeared on the second CT). Clinical and radiological characteristics of the three groups were compared using univariate and multivariate logistic regression analyses. Results: The relative incidences of stable persistence, progressive persistence, and clinical recurrence were 56.1% (60/107), 15.0% (16/107), and 29.0% (31/107), respectively. Multivariate analysis between the clinical recurrence (29.0%) and persistence (71.0%) groups revealed various independent factors for prediction of clinical recurrence. These included longer interval between the two CT examinations (median 2.67 vs. 1.79 years; p = 0.021), a smaller number of thyroid surgeries (1.16 +/- 0.45 vs. 1.55 +/- 0.81; p = 0.002), and a history of neck dissection at the location of the largest locoregional recurrence (70.0% vs. 31.4%; p < 0.001). There was no significant independent factor for differentiation between the stable persistence (78.9%; 60/76) and progressive persistence (21.1%; 16/76) groups. The results may have been influenced by selection bias because this study included only surgically proven cases. Conclusions: With regard to cervical locoregional recurrence of DTC, active surveillance may be favored because more than a half of the cases are structurally persistent and stable. However, meticulous evaluation is necessary to detect progressive persistence and clinical recurrence, considering various clinical factors.
引用
收藏
页码:1490 / 1499
页数:10
相关论文
共 50 条
  • [1] Impact of FDG-PET Computed Tomography for Surgery of Recurrent or Persistent Differentiated Thyroid Carcinoma
    Weber, T.
    Ohlhauser, D.
    Hillenbrand, A.
    Henne-Bruns, D.
    Reske, S. N.
    Luster, M.
    HORMONE AND METABOLIC RESEARCH, 2012, 44 (12) : 904 - 908
  • [2] The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer
    Aras, Guelseren
    Gultekin, Salih Sinan
    Kucuk, Nuriye Ozlem
    NUCLEAR MEDICINE COMMUNICATIONS, 2008, 29 (10) : 880 - 884
  • [3] Reoperation for Recurrent/Persistent Well-Differentiated Thyroid Cancer
    Pai, Sara I.
    Tufano, Ralph P.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2010, 43 (02) : 353 - +
  • [4] Central Compartment Reoperation for Recurrent/Persistent Differentiated Thyroid Cancer
    Agrawal, Ritesh
    Mishra, Anjali
    Mishra, Saroj Kanta
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 : S250 - S250
  • [5] Central Compartment Reoperation for Recurrent/Persistent Differentiated Thyroid Cancer
    Ritesh Agrawal
    Anjali Mishra
    Saroj Kanta Mishra
    Annals of Surgical Oncology, 2011, 18 : 250 - 250
  • [6] Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
    Nascimento, C.
    Borget, I.
    Al Ghuzlan, A.
    Deandreis, D.
    Chami, L.
    Travagli, J. P.
    Hartl, D.
    Lumbroso, J.
    Chougnet, C.
    Lacroix, L.
    Baudin, E.
    Schlumberger, M.
    Leboulleux, S.
    ENDOCRINE-RELATED CANCER, 2011, 18 (02) : R29 - R40
  • [7] Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018
    Lin, Yansong
    Huang, Huiqiang
    Guo, Ye
    Chen, Libo
    Bao, Jiandong
    Chen, Ge
    Chen, Libo
    Cui, Yali
    Ding, Yong
    Guan, Haixia
    Guo, Ye
    Gao, Zairong
    Huang, Huiqiang
    Huang, Rui
    Huang, Tao
    Hou, Xiaorong
    He, Xiayun
    Li, Mei
    Li, Shaohua
    Li, Xiaoyi
    Li, Xuena
    Li, Yujun
    Liang, Zhiyong
    Luo, Yukun
    Lin, Yansong
    Lyu, Jing
    Ma, Qingjie
    Niu, Lijuan
    Sun, Wenhai
    Wang, Feng
    Wang, Renfei
    Wei, Feng
    Xia, Yu
    Yang, Aiming
    Zhang, Bin
    Zhang, Bo
    Zhang, Guang
    Zhang, Hong
    Zhang, Li
    Zheng, Xiangqian
    An, Rui
    Fang, Jugao
    Fan, Youben
    Gao, Ming
    Guo, Zhuming
    Huang, Gang
    Ji, Qinghai
    Jiang, Ningyi
    Jiang, Yuxin
    Kuang, Anren
    CHINESE JOURNAL OF CANCER RESEARCH, 2019, 31 (01) : 99 - 116
  • [8] Central Compartment Reoperation for Recurrent/Persistent Differentiated Thyroid Cancer: Patterns of Recurrence, Morbidity, and Prediction of Postoperative Hypocalcemia
    Roh, Jong-Lyel
    Kim, Jin-Man
    Park, Chan Il
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (05) : 1312 - 1318
  • [9] Central Compartment Reoperation for Recurrent/Persistent Differentiated Thyroid Cancer: Patterns of Recurrence, Morbidity, and Prediction of Postoperative Hypocalcemia
    Jong-Lyel Roh
    Jin-Man Kim
    Chan Il Park
    Annals of Surgical Oncology, 2011, 18 : 1312 - 1318
  • [10] Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version)
    Chinese Society of Clinical Oncology(CSCO)diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer working group
    ChineseJournalofCancerResearch, 2019, 31 (01) : 99 - 116